ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials

Author： Malyguine Anatoli M.   Strobl Susan   Dunham Kimberly   Shurin Michael R.   Sayers Thomas J.  

Publisher： MDPI

E-ISSN： 2073-4409|1|2|111-126

ISSN： 2073-4409

Source： Cells, Vol.1, Iss.2, 2012-05, pp. : 111-126

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety Monitoring in Clinical Trials

By Yao Bin   Zhu Li   Jiang Qi   Xia H. Amy  

Pharmaceutics, Vol. 5, Iss. 1, 2013-01 ,pp. : 94-106

MDPI

Access to resources Recommend Favorite

T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials

By Brezar Vedran   Godot Véronique   Cheng Liang   Su Lishan   Lévy Yves   Seddiki Nabila  

Vaccines, Vol. 4, Iss. 3, 2016-09 ,pp. : 30-30

MDPI

Access to resources Recommend Favorite

An Enhanced ELISPOT Assay for Sensitive Detection of Antigen-Specific T Cell Responses to Borrelia burgdorferi

By Jin Chenggang   Roen Diana R.   Lehmann Paul V.   Kellermann Gottfried H.  

Cells, Vol. 2, Iss. 3, 2013-09 ,pp. : 607-620

MDPI

Access to resources Recommend Favorite

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints

By Kalyuzhny Alexander E.  

Cells, Vol. 1, Iss. 1, 2011-09 ,pp. : 3-4

MDPI

Access to resources Recommend Favorite

Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials

By Au Minnie   Emeto Theophilus I.   Power Jacinta   Vangaveti Venkat N.   Lai Hock C.  

Biomedicines, Vol. 4, Iss. 3, 2016-08 ,pp. : 20-20

MDPI

Access to resources Recommend Favorite